- Company
- Walgreens Boots Alliance
- Role
- Executive Chairman
- Est. Net Worth
- $10 Billion
- Stage
- Elite
- Industry
- Healthcare
Stefano Pessina
Executive Chairman at Walgreens Boots Alliance
About
Stefano Pessina transformed the global pharmacy industry through decades of acquisitions, merging his family's Italian pharmaceutical distribution company with Alliance UniChem, then engineering Alliance Boots' merger with Walgreens to create Walgreens Boots Alliance — the world's largest pharmacy chain with over 13,000 stores across the United States, Europe, and Asia. His vision was that pharmacies would evolve from drug dispensaries into front-line healthcare delivery points, offering vaccinations, health screenings, and clinical services at scale.
Current Company
Walgreens Boots Alliance — Executive Chairman
Consolidating Global Pharmacy
Stefano Pessina inherited a small pharmaceutical distribution company from his family in Naples and spent four decades turning it into the largest pharmacy-led health and well-being enterprise in the world. His strategy was relentless consolidation: merging with UniChem to form Alliance UniChem, then acquiring Boots in the UK to create Alliance Boots, and finally engineering the $17 billion merger with Walgreens in 2014 to form Walgreens Boots Alliance.
The combined entity operates over 13,000 pharmacies worldwide and distributes pharmaceutical products to over 200,000 locations across the globe. Pessina's vision was that scale in pharmacy wasn't just about purchasing power — it was about transforming the corner drugstore into a frontline healthcare delivery point where patients could receive vaccinations, health screenings, and clinical consultations.
Pharmacy as Healthcare's Front Door
Under Pessina's leadership, Walgreens Boots Alliance invested heavily in expanding clinical services within its pharmacy network — offering flu shots, COVID-19 vaccinations, and basic health screenings at scale. The thesis was that pharmacies, as the most accessible healthcare touchpoints in most communities, could reduce the burden on hospitals and clinics while improving preventive care.
Pessina's career demonstrated that European-style consolidation strategies could work in American healthcare — an industry famously resistant to efficiency. His quiet, deal-driven approach to empire-building contrasted with the flashier styles of American tech entrepreneurs, but the results were comparable: a single company spanning 25 countries and touching the health of hundreds of millions of patients.